On March 5, 2019, Acantha LLC (“Plaintiff”) filed a complaint against NuVasive, Inc. (“Defendant”) for infringement of U.S. Patent No. 6,261,291 (“the ‘291 Patent”), which was reissued as RE43,008 (“the ‘008 Patent”). The ‘008 Patent is owned by the Plaintiff and is drawn to an orthopedic implant assembly and methods of using it.
The Plaintiff is asserting that the Defendant is infringing the ‘008 Patent by making, using, offering for sale, selling, and/or importing the the NuVasive Helix Anterior Cervical Plate (“ACP”) family of systems (NuVasive Helix ACP, NuVasive Helix Mini ACP, NuVasive Helix-T ACP, and NuVasive Helix-Revolution ACP), the Halo Anterior Lumbar Plate System, the Traverse Plate System, the Brigade Anterior Plate System, the CoRoent XL-F implant system, and additional implant products. The Plaintiff also alleges that the Defendant is inducing infringement by directing others to infringe the ‘008 Patent and is indirectly and willfully infringing the Patent.
The case remains pending and is captioned 4:19-cv-10656 (E.D. Mich.).
By: April Breyer Menon